Mizuho Securities Reiterates Selecta Biosciences (SELB) at Buy

March 10, 2022 5:34 PM EST Send to a Friend
Mizuho Securities analyst Uy Ear reiterated a Buy rating and $8.00 price target on Selecta Biosciences (NASDAQ: SELB), following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login